178 related articles for article (PubMed ID: 30785510)
1. Ursodeoxycholic acid in the prevention of gallstones in patients subjected to Roux-en-Y gastric bypass1.
Machado FHF; Castro Filho HF; Babadopulos RFAL; Rocha HAL; Rocha JLC; Moraes Filho MO
Acta Cir Bras; 2019 Feb; 34(1):e20190010000009. PubMed ID: 30785510
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial).
Boerlage TCC; Haal S; Maurits de Brauw L; Acherman YIZ; Bruin S; van de Laar AWJM; Moes DE; van Wagensveld BA; de Vries CEE; van Veen R; Schouten R; Dijkgraaf MG; Fockens P; Gerdes VEA; Voermans RP
BMC Gastroenterol; 2017 Dec; 17(1):164. PubMed ID: 29262795
[TBL] [Abstract][Full Text] [Related]
3. Patients developed symptomatic gallstones between 3 and 21 months after Roux-en-Y gastric bypass (RYGB), neither prophylactic cholecystectomy nor treatment with ursodeoxycholic acid is necessary after open RYGB.
Sarr MG
Surg Obes Relat Dis; 2006; 2(2):233; author reply 233. PubMed ID: 16925352
[No Abstract] [Full Text] [Related]
4. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial.
Haal S; Guman MSS; Boerlage TCC; Acherman YIZ; de Brauw LM; Bruin S; de Castro SMM; van Hooft JE; van de Laar AWJM; Moes DE; Schouten M; Schouten R; van Soest EJ; van Veen RN; de Vries CEE; Fockens P; Dijkgraaf MGW; Gerdes VEA; Voermans RP
Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):993-1001. PubMed ID: 34715031
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Ursodeoxycholic Acid in the Prevention of Cholelithiasis After Sleeve Gastrectomy.
Coupaye M; Calabrese D; Sami O; Siauve N; Ledoux S
Obes Surg; 2019 Aug; 29(8):2464-2469. PubMed ID: 30945151
[TBL] [Abstract][Full Text] [Related]
6. Randomized, Prospective Comparison of Ursodeoxycholic Acid for the Prevention of Gallstones after Sleeve Gastrectomy.
Adams LB; Chang C; Pope J; Kim Y; Liu P; Yates A
Obes Surg; 2016 May; 26(5):990-4. PubMed ID: 26342481
[TBL] [Abstract][Full Text] [Related]
7. Intraoperative ultrasound and prophylactic ursodiol for gallstone prevention following laparoscopic gastric bypass.
Scott DJ; Villegas L; Sims TL; Hamilton EC; Provost DA; Jones DB
Surg Endosc; 2003 Nov; 17(11):1796-802. PubMed ID: 12958683
[TBL] [Abstract][Full Text] [Related]
8. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double-blind placebo-controlled trial.
Miller K; Hell E; Lang B; Lengauer E
Ann Surg; 2003 Nov; 238(5):697-702. PubMed ID: 14578732
[TBL] [Abstract][Full Text] [Related]
9. Elective cholecystectomy after Roux-en-Y gastric bypass: why should asymptomatic gallstones be treated differently in morbidly obese patients?
Swartz DE; Felix EL
Surg Obes Relat Dis; 2005; 1(6):555-60. PubMed ID: 16925290
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic Acid for 6 Months After Bariatric Surgery Is Impacting Gallstone Associated Morbidity in Patients with Preoperative Asymptomatic Gallstones.
Della Penna A; Lange J; Hilbert J; Archid R; Königsrainer A; Quante M
Obes Surg; 2019 Apr; 29(4):1216-1221. PubMed ID: 30604076
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Ursodeoxycholic Acid for the Prevention of Gallstone Formation After Gastrectomy in Patients With Gastric Cancer: The PEGASUS-D Randomized Clinical Trial.
Lee SH; Jang DK; Yoo MW; Hwang SH; Ryu SY; Kwon OK; Hur H; Man Yoon H; Eom BW; Ahn HS; Son T; Song KY; Lee HH; Choi MG; An JY; Lee SI; Lee KH; Ahn S; Park YS; Park DJ;
JAMA Surg; 2020 Aug; 155(8):703-711. PubMed ID: 32584935
[TBL] [Abstract][Full Text] [Related]
12. Risk of biliary complications in bariatric surgery.
Desbeaux A; Hec F; Andrieux S; Fayard A; Bresson R; Pruvot MH; Mulliez E
J Visc Surg; 2010 Aug; 147(4):e217-20. PubMed ID: 20920904
[TBL] [Abstract][Full Text] [Related]
13. Incidence of symptomatic gallstones after gastric bypass: is prophylactic treatment really necessary?
Caruana JA; McCabe MN; Smith AD; Camara DS; Mercer MA; Gillespie JA
Surg Obes Relat Dis; 2005; 1(6):564-7; discussion 567-8. PubMed ID: 16925292
[TBL] [Abstract][Full Text] [Related]
14. Prevention of gallstones by ursodeoxycholic acid after cardiac surgery.
Ai T; Azemoto R; Saisho H
J Gastroenterol; 2003; 38(11):1071-6. PubMed ID: 14673725
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of ursodeoxycholic acid in preventing new-onset symptomatic gallstone disease after Roux-en-Y gastric bypass surgery.
Haal S; Guman MSS; de Brauw LM; Schouten R; van Veen RN; Fockens P; Gerdes VEA; Voermans RP; Dijkgraaf MGW
Br J Surg; 2022 Oct; 109(11):1116-1123. PubMed ID: 35979609
[TBL] [Abstract][Full Text] [Related]
16. The Role of Ursodeoxycholic Acid (UDCA) in Cholelithiasis Management After One Anastomosis Gastric Bypass (OAGB) for Morbid Obesity: Results of a Monocentric Randomized Controlled Trial.
Pizza F; D'Antonio D; Lucido FS; Tolone S; Del Genio G; Dell'Isola C; Docimo L; Gambardella C
Obes Surg; 2020 Nov; 30(11):4315-4324. PubMed ID: 32583297
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of incidence of cholelithiasis after bariatric surgery in subjects treated or not treated with ursodeoxycholic acid.
Coupaye M; Calabrese D; Sami O; Msika S; Ledoux S
Surg Obes Relat Dis; 2017 Apr; 13(4):681-685. PubMed ID: 28089591
[TBL] [Abstract][Full Text] [Related]
18. Effect of oral ursodeoxycholic acid on cholelithiasis following laparoscopic sleeve gastrectomy for morbid obesity.
Nabil TM; Khalil AH; Gamal K
Surg Obes Relat Dis; 2019 Jun; 15(6):827-831. PubMed ID: 31113752
[TBL] [Abstract][Full Text] [Related]
19. Ursodeoxycholic acid for the prevention of gall stones after laparoscopic sleeve gastrectomy: a prospective controlled study.
Salman MA; Salman A; Mohamed US; Hussein AM; Ameen MA; Omar HSE; Elewa A; Hamdy A; Elias AA; Tourky M; Helal A; Mahmoud AA; Aljarad F; Moustafa A; Shaaban HE; Nashaat A; Hussein AM; Omar T; Balamoun H
Surg Endosc; 2022 Sep; 36(9):6396-6402. PubMed ID: 35020052
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: statistical analysis plan for a randomised controlled trial (UPGRADE trial).
Haal S; Guman MSS; de Brauw LM; van Veen RN; Schouten R; Fockens P; Gerdes VEA; Dijkgraaf MGW; Voermans RP
Trials; 2020 Jul; 21(1):676. PubMed ID: 32703246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
